리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 09월
페이지 정보:영문 277 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 이 치료(Lice Treatment) 시장은 2030년까지 13억 달러에 달할 전망
2023년에 10억 달러로 추정되는 세계의 이 치료 시장은 분석 기간인 2023-2030년에 CAGR 4.2%로 성장하며, 2030년에는 13억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 OTC 의약품은 CAGR 4.5%를 기록하며, 분석 기간 종료시에는 8억 7,750만 달러에 달할 것으로 예측됩니다. 처방약 부문의 성장률은 분석 기간 중 CAGR 3.8%로 추정됩니다.
미국 시장은 2억 7,390만 달러로 추정, 중국은 CAGR 7.1%로 성장 예측
미국의 이 치료 시장은 2023년에 2억 7,390만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2023-2030년의 CAGR을 7.1%로서 2030년까지 2억 7,210만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.5%와 4.5%로 예측됩니다. 유럽에서는 독일이 CAGR 2.5%로 성장할 것으로 예측됩니다.
세계의 이 치료 시장 - 주요 동향과 촉진요인 정리
이 치료는 공중위생에 어떻게 필수적인가?
이 치료는 공중위생을 유지하는데 있어서 중요한 역할을 담당하고 있습니다. 특히 학교나 어린이집과 같은 공동 생활 환경에서는 이가 빠르게 확산될 수 있습니다. 효과적인 이 관리로 가려움증과 염증과 같은 감염으로 인한 불편함을 완화할 뿐만 아니라, 긁힘으로 인한 2차 감염을 예방하는 데에도 필수적입니다. 또한 적극적인 이 치료와 예방은 교육 현장의 혼란을 최소화하고, 이 감염으로 인한 사회적 낙인을 줄이는 데에도 매우 중요합니다. 신속하고 효과적인 대응을 통해 지역사회는 더 높은 위생 및 건강 수준을 유지하고 이 확산을 억제할 수 있습니다.
이가 치료의 기능성을 높이는 혁신이란?
이 치료의 기술 혁신은 효과와 안전성을 높이고, 무해한 솔루션에 초점을 맞추고, 사용자의 편의성을 향상시키는 데 초점을 맞추었습니다. 최근 두피에 자극이 심하고 특히 어린이에게 위험할 수 있는 기존 살충제를 사용하지 않고 천연 효소나 식물성 성분을 사용하여 이가 제거할 수 있는 치료법이 개발되고 있습니다. 이러한 새로운 제제는 이가 성충을 표적으로 삼을 뿐만 아니라 이 알의 수명 주기를 효과적으로 파괴하여 보다 종합적으로 이 확산을 관리할 수 있습니다. 또한 마이크로 충전 기술로 이가 죽이는 전기 빗, 머리카락에서 이나 이가 직접 흡입하도록 설계된 진공 시스템과 같은 물리적 이 제거 방법도 개선되어 화학 물질을 사용하지 않는 치료법도 제공되고 있습니다.
이 치료는 가정과 교육 기관에 어떤 영향을 미칩니 까?
이 치료가 가정과 교육기관에 미치는 영향은 매우 커서 아이들의 건강 상태와 학교 운영 효율성에 영향을 미칩니다. 효과적인 이 대책은 아이들이 이 때문에 불편함과 산만함에서 벗어나 더 나은 학습 환경을 조성하고 높은 출석률을 유지할 수 있도록 도와줍니다. 가정에서도 신뢰할 수 있는 안전한 이 구제 옵션이 있다는 것은 이가 퍼진 것을 신속하게 해결하여 아이들의 정신적, 육체적 불편함과 부모들의 스트레스를 줄일 수 있다는 것을 의미합니다. 이 관리를 위한 정보에 입각한 정책과 실천을 시행하는 학교는 확산을 방지하고, 확산 관리보다 교육에 중점을 두어 보다 건강하고 포용적인 지역 환경을 조성할 수 있습니다.
이가 치료 시장의 성장을 가속하는 동향은 무엇인가?
보다 안전하고 효과적인 치료법에 대한 인식이 높아지고 전 세계에서 이 발생률이 증가하는 등 몇 가지 동향이 이 치료 시장의 성장을 주도하고 있습니다. 학부모와 학교가 기존 화학적 치료의 잠재적 위험성에 대해 더 많이 알게 됨에 따라 효과적이고 피부 및 환경 친화적인 치료법에 대한 수요가 증가하고 있습니다. 또한 기존 화학물질 기반 치료법에 대한 내성으로 인해 내성이 생긴 이들에 대응할 수 있는 새로운 제형과 방법이 요구되고 있습니다. 또한 이 예방 및 치료와 관련된 공중보건 노력과 교육 캠페인은 인식 제고와 이 감염에 대한 낙인을 없애고 사람들이 보다 신속하고 효과적인 치료를 받을 수 있도록 장려함으로써 시장 성장에 기여하고 있습니다. 이러한 추세는 이 치료 시장의 혁신과 개척을 촉진하고 소비자 니즈와 공중 보건 기준을 충족시키기 위해 지속적으로 진화할 수 있도록 보장합니다.
조사 대상 기업의 예(총 43건)
Alliance Pharma Plc
Apothecary Products, LLC.
FloSonix
G. Pohl-Boskamp GmbH & Co.KG
Leeford Healthcare Ltd.
Marico Ltd.
MooGoo Skin Care.
NitNOT Eco Head Lice Treatments
NitWits
Oystershell Consumer Health, Inc.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장의 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Lice Treatment Market to Reach US$1.3 Billion by 2030
The global market for Lice Treatment estimated at US$1.0 Billion in the year 2023, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. OTC Medication, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$877.5 Million by the end of the analysis period. Growth in the Prescription Medication segment is estimated at 3.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$273.9 Million While China is Forecast to Grow at 7.1% CAGR
The Lice Treatment market in the U.S. is estimated at US$273.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$272.1 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.
Global Lice Treatment Market - Key Trends and Drivers Summarized
How Is Lice Treatment Essential for Public Health and Hygiene?
Lice treatment plays a crucial role in maintaining public health and hygiene, particularly in communal environments like schools and daycare centers where infestations can spread quickly. Effective lice management is vital not only to alleviate the discomfort of infestation, including itching and irritation but also to prevent the secondary infections that can occur from scratching. Furthermore, proactive lice treatment and prevention are critical in minimizing disruptions in educational settings and reducing the social stigma that can be associated with lice infestations. By ensuring that infestations are dealt with swiftly and effectively, communities can maintain higher standards of hygiene and health, and reduce the spread of lice.
What Innovations Are Enhancing the Functionality of Lice Treatment?
Innovations in lice treatment are enhancing its effectiveness and safety, focusing on non-toxic solutions and improving user convenience. Recent advancements include the development of treatments that use natural enzymes or plant-based ingredients to kill lice without the use of traditional insecticides, which can be harsh on the scalp and potentially hazardous, especially for children. These newer formulations not only target adult lice but also effectively disrupt the life cycle of nits (lice eggs), ensuring more comprehensive management of infestations. Additionally, there are improvements in the physical methods of lice removal, such as electric combs that use microcharge technology to kill lice and vacuum systems designed to suction out lice and nits directly from the hair, offering non-chemical treatment alternatives.
How Does Lice Treatment Impact Families and Educational Institutions?
The impact of lice treatment on families and educational institutions is significant, influencing both the physical health of children and the operational efficiency of schools. Effective lice management ensures that children are free from the discomfort and distraction caused by lice, promoting a better learning environment and keeping school attendance high. For families, having reliable and safe lice treatment options means quicker resolution of infestations, lessening the emotional and physical discomfort for children and the stress on parents. Schools that implement informed policies and practices for managing lice can prevent widespread outbreaks and maintain a focus on education rather than infestation management, fostering a healthier and more inclusive community environment.
What Trends Are Driving Growth in the Lice Treatment Market?
Several trends are driving growth in the lice treatment market, including increased awareness about safer and more effective treatment options and the global rise in the incidence of lice infestations. As parents and schools become more informed about the potential hazards of traditional chemical treatments, there is growing demand for treatments that are both effective and gentle on the skin and environment. Additionally, resistance to older, chemical-based treatments has led to the need for new formulations and methods that can address resistant strains of lice. Public health initiatives and educational campaigns about lice prevention and treatment are also contributing to market growth by raising awareness and destigmatizing infestations, encouraging people to seek treatment more promptly and effectively. These trends are fostering innovation and development within the lice treatment market, ensuring it continues to evolve to meet consumer needs and public health standards.
Select Competitors (Total 43 Featured) -
Alliance Pharma Plc
Apothecary Products, LLC.
FloSonix
G. Pohl-Boskamp GmbH & Co.KG
Leeford Healthcare Ltd.
Marico Ltd.
MooGoo Skin Care.
NitNOT Eco Head Lice Treatments
NitWits
Oystershell Consumer Health, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Lice Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increased Incidence of Head Lice Infestations Drives Demand for Effective Lice Treatment Solutions
Health and Safety Concerns Propel the Adoption of Natural and Non-Toxic Lice Treatments
Focus on Head Lice Management in Schools Influence Demand for Regular Lice Screening and Treatment Solutions
Enhancements in Application and Effectiveness of Lice Treatment Devices Boost Consumer Acceptance
Market Expansion Through Online Retail Channels Enhances Accessibility of Lice Treatments
Integration of Telemedicine in Dermatology Supports Growth in Lice Treatment Consultations
Increasing Consumer Preference for Home-Based Remedies Influences Product Innovations
Social Stigma and Hygiene Concerns Drive Innovations in Discreet Lice Treatment Products
Growing Number of Daycare and Child Care Centers Increases Demand for Lice Prevention Products
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Lice Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Lice Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for OTC Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for OTC Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for OTC Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Prescription Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Prescription Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Prescription Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 21: USA Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: USA 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 23: USA Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: Canada 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 29: Canada Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
JAPAN
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 32: Japan Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Japan 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 35: Japan Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
CHINA
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 38: China Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: China Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: China 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 41: China Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
EUROPE
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Lice Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Europe 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
FRANCE
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 53: France Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: France Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: France 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
GERMANY
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 59: Germany Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Germany 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
ITALY
TABLE 65: Italy Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Italy 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
UNITED KINGDOM
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 71: UK Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: UK Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: UK 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
SPAIN
TABLE 77: Spain Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Spain Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Spain 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 80: Spain Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
RUSSIA
TABLE 83: Russia Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Russia Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Russia 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 86: Russia Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Lice Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
AUSTRALIA
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 104: Australia Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Australia Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Australia 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 107: Australia Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
INDIA
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 110: India Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: India Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: India 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 113: India Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 116: South Korea Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: South Korea Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: South Korea 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 119: South Korea Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Asia-Pacific Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
LATIN AMERICA
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 128: Latin America Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 129: Latin America Historic Review for Lice Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Latin America 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 131: Latin America Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 137: Argentina Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Argentina Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Argentina 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 140: Argentina Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
BRAZIL
TABLE 143: Brazil Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Brazil Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Brazil 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 146: Brazil Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
MEXICO
TABLE 149: Mexico Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Mexico Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Mexico 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 152: Mexico Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of Latin America Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of Latin America 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
MIDDLE EAST
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 161: Middle East Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 162: Middle East Historic Review for Lice Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Middle East 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 164: Middle East Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
IRAN
TABLE 170: Iran Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Iran Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Iran 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 173: Iran Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
ISRAEL
TABLE 176: Israel Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Israel Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Israel 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 179: Israel Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Saudi Arabia Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Saudi Arabia 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 188: UAE Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: UAE Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: UAE 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 191: UAE Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Middle East Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Middle East 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
AFRICA
Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 200: Africa Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Africa Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Africa 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
TABLE 203: Africa Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030